EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation

Shikha Awasthi iD

Nanoscale Advances · 2026 · 8 (18) · 5016-5041

DOI: 10.1039/d6na00491a ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanoscale Advances, 2026. Verfasst von Shikha Awasthi. Beteiligte Einrichtung: Jagran School of Pharmacy, Jagran Lakecity University Bhopal - 462044 Madhya Pradesh India awas.shikha2212@gmail.com. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

nHAp composites are promising, but these composites can trigger a number of toxicity-related responses depending on the particle characteristics, composite composition, dosage, and biological exposure conditions (the figure was created using BioRender).

Autor:innen und Institutionen

  • Jagran School of Pharmacy, Jagran Lakecity University Bhopal - 462044 Madhya Pradesh India awas.shikha2212@gmail.com.

ORCID-Profile: Shikha Awasthi

Zitieren

APA

Awasthi, S. (2026). Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation. Nanoscale Advances, 8(18), 5016-5041. https://doi.org/10.1039/d6na00491a

Vancouver

Awasthi S. Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation. Nanoscale Advances. 2026;8(18):5016-5041. doi:10.1039/d6na00491a

BibTeX
@article{Awasthi2026,
  author = {Awasthi, Shikha},
  title = {Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation},
  journal = {Nanoscale Advances},
  year = {2026},
  volume = {8},
  number = {18},
  pages = {5016--5041},
  doi = {10.1039/d6na00491a}
}
Kostenlos starten →